BODISEN BIOTECH, INC: 10-K filed 2012-04-17
What BODISEN BIOTECH, INC reported in its annual report filed 2012-04-17 (fiscal FY 2011): 38 published measures, 76 facts as tagged in accession 0001013762-12-000873.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-04-17
- Fiscal period
- fiscal FY 2011
- Accession
- 0001013762-12-000873 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BODISEN BIOTECH, INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 36,933,660 | USD | |
| At 2010-12-31 | 48,038,180 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,755,839 | USD | |
| At 2010-12-31 | 5,200,727 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 34,177,821 | USD | |
| At 2010-12-31 | 42,837,453 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 935,375 | USD | |
| At 2010-12-31 | 3,675,209 | USD | |
| At 2009-12-31 | 4,824,135 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -2,310,372 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -4,170,313 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -2,816,911 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -721,879 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 12,686 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 558,916 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -154,800 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,479,400 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 142,114 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -2,038,316 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -14,360,404 | USD | |
| At 2010-12-31 | -12,050,032 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 21,510,250 | shares | 365 |
| 2010-01-01 to 2010-12-31 | 18,825,318 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 21,510,250 | shares | 365 |
| 2010-01-01 to 2010-12-31 | 18,825,318 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -0.11 | USD/shares | 365 |
| 2010-01-01 to 2010-12-31 | -0.22 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -0.11 | USD/shares | 365 |
| 2010-01-01 to 2010-12-31 | -0.22 | USD/shares | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 22,003,784 | USD | |
| At 2010-12-31 | 22,870,340 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-12-31 | 1,400,000 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -2,260,830 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -4,144,112 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 8,866,002 | USD | |
| At 2010-12-31 | 11,573,564 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 145,747 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 92,956 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,755,839 | USD | |
| At 2010-12-31 | 3,683,727 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 702,253 | USD | |
| At 2010-12-31 | 1,256,681 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,840,546 | USD | |
| At 2010-12-31 | 4,499,673 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 4,336,750 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 4,997,478 | USD | 365 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,149,262 | USD | |
| At 2010-12-31 | 1,198,134 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 2,075,920 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 853,366 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 21,510,250 | shares | |
| At 2010-12-31 | 21,510,250 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 8,876,044 | USD | |
| At 2010-12-31 | 15,225,304 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 4,852,720 | USD | |
| At 2010-12-31 | 4,813,409 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 81,437 | USD | |
| At 2010-12-31 | 811,181 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 6,944 | USD | |
| At 2010-12-31 | 8,598 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -8,659,632 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -2,418,316 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,491,847 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 4,558,294 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,832,487 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 924,633 | USD | 365 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -111,757 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -5,461 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -49,542 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -26,201 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -89,152 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 3,803,357 | USD | 365 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 892,486 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 168,920 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -590,891 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 1,153,772 | USD | 365 |
Inspect the source
- Entity
- BODISEN BIOTECH, INC / CIK 0001178552
- Captured
- SEC response SHA-256
89770d584def8dad8ea54c6f00643192bc6262403f4621a52d3e684041931947
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001178552.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))